Curcumin Sensitizes Chemotherapeutic Drugs Via Modulation of PKC, telomerase, NF-κB and HDAC in Breast Cancer

Abstract

Curcumin may be of considerable value in synergistic therapy of cancer such that the drug dose level could be minimized reducing the associated toxicity.